Our research focuses on the epigenetic prioritisation of genes driving common pathologies and the subsequent development of pharmacogenetic therapies. We are a collaborative research team that focusses on resolving the epigenetic mechanisms that underlie complex disease and translating these findings into the development of personalised pharmacological interventions.